Nasdaq

Vistin Pharma ASA : Invitation to presentation of Q3 2017 results

23-10-2017
 
Oslo, 23 October 2017

Vistin Pharma ASA (OSE: VISTIN), a producer of high quality API's for the international pharmaceutical industry, will release its third quarter 2017 results on Friday 27 October 2017.

The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar Manum at

08:30 CET at Carnegie AS, Fjordalleen 16, Oslo,

Norway. The presentation will be held in Norwegian.


  


The quarterly report and the presentation material will be available on www.vistin.com/investors and www.newsweb.no, as well as on news wires.

Vistin Pharma welcomes all interested parties.

For further information, please contact:

Gunnar Manum


CFO


+47 95 17 91 90


gunnar.manum@vistin.com

 
 
 
 
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Vistin Pharma ASA via GlobeNewswire

HUG#2143529